Incomplete Plasmodium falciparum growth inhibition following piperaquine treatment translates into increased parasite viability in the in vitro parasite reduction ratio assay

Antimalarial resistance to the first-line partner drug piperaquine (PPQ) threatens the effectiveness of artemisinin-based combination therapy. In vitro piperaquine resistance is characterized by incomplete growth inhibition, i.e. increased parasite growth at higher drug concentrations. However, the...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Annabelle Walz, Sibylle Sax, Christian Scheurer, Balint Tamasi, Pascal Mäser, Sergio Wittlin
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2024-04-01
Schriftenreihe:	Frontiers in Cellular and Infection Microbiology
Schlagworte:	PRR assay drug resistance piperaquine parasite viability growth inhibition assay 4-aminoquinoline
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fcimb.2024.1396786/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!